(2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid

• Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dos… Ended
  2023-506000-50-00 Phase II 7 countries Astrazeneca AB
• A trial to learn how AZD4604 acts in the body and how safe it is in adults with asthma Ended
  2023-510291-32-00 Phase II 3 countries AstraZeneca AB

Showing 1–2 of 2 trials